| Literature DB >> 26037293 |
Gyung-Min Park1, Jae-Hwan Lee2, Seung-Whan Lee3, Sung-Cheol Yun4, Young-Hak Kim5, Young-Rak Cho6, Eun Ha Gil1, Tae-Seok Kim1, Chan Joon Kim1, Jung Sun Cho1, Mahn-Won Park1, Sung Ho Her1, Dong Hyun Yang7, Joon-Won Kang7, Tae-Hwan Lim7, Eun Hee Koh8, Woo Je Lee8, Min-Seon Kim8, Ki-Up Lee8, Hong-Kyu Kim9, Jaewon Choe9, Joong-Yeol Park8.
Abstract
There are limited data on the impact of diabetes mellitus (DM) on the risk of subclinical atherosclerosis. Therefore, we sought to investigate the impact of DM on the risk of subclinical atherosclerosis in asymptomatic subjects. We analyzed 2,034 propensity score-matched asymptomatic subjects who underwent coronary computed tomographic angiography (mean age 55.9 ± 8.2 years; men 1,725 [84.8%]). Coronary artery calcium score, degree and extent of coronary artery disease (CAD), and clinical outcomes were assessed. High-risk CAD was defined as at least 2-vessel coronary disease with proximal left anterior descending artery involvement, 3-vessel disease, or left main disease. Compared with subjects without DM, those matched with DM had higher coronary artery calcium score (89.9 ± 240.4 vs 62.8 ± 179.5, p = 0.004) and more significant CAD (≥50% diameter stenosis, 15.2% vs 10.2%, p = 0.001), largely in the form of 1-vessel disease (10.8% vs 7.3%, p = 0.007). However, there were no significant differences between matched pairs in significant CAD in the left main or proximal left anterior descending artery (5.3% vs 3.8%, p = 0.138), multivessel disease (4.4% vs 2.9%, p = 0.101), and high-risk CAD (4.3% vs 2.7%, p = 0.058). During the follow-up period (median 21.8, interquartile range 15.2 to 33.4 months), there was no significant difference in the composite of all-cause death, myocardial infarction, acute coronary syndrome, and coronary revascularization between 2 groups (hazard ratio 1.438, 95% confidence interval 0.844 to 2.449, p = 0.181). In asymptomatic subjects, those matched with DM have more subclinical atherosclerosis, mainly confined to non-high-risk CAD, than those matched without DM, and there are no differences in high-risk CAD and clinical outcomes.Entities:
Mesh:
Year: 2015 PMID: 26037293 DOI: 10.1016/j.amjcard.2015.04.046
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778